I imagine this one will start to move again as the time of trial commencement approaches....worth a punt IMHOP
AnnaP
Sydney - Friday - November 8: (RWE) - Ventracor Ltd today announced it was planning to seek approval before the end of November to begin human implant trials of its VentrAssist heart assist device. Managing director and CEO Mr Michael Spooner told the annual meeting that Ventracor was in the final stages of collecting data to support its submissions to the Ethics Committee of The Alfred hospital in Melbourne, where the first series of implants would be performed. "Once the submission to the Ethics Committee is completed, we will work closely in support of The Alfred hospital and its surgical team, led by Professor Don Esmore, in preparing for the forthcoming clinical trial. "With the best currently available information and recognising that The Alfred team is responsible for the conduct of the clinical trial, it is expected that the lead-up process to commence human implants may take eight to 10 weeks," Mr Spooner said. "Ventracor has sufficient funds to undertake the Pilot Trial in Australia and to commence our global Pivotal Trial. "Ventracor is well positioned to improve the quality of life for hundreds of thousands of people worldwide suffering heart failure by obtaining a significant share of the massive heart assist market, which is expected to grow between $US7.5 billion and $US12 billion in the next few years", he said. Shares in Ventracor fell 1c to 81c.
VCR Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held